IP Library › Granted Patent US 7,442,535
Granted Patent B2
US 7,442,535 · App. 11/759,953 · Granted Oct 28, 2008

Fusion protein incorporating a cysteinized ribonuclease

Assignee: Alfacell Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,442,535
App. No.
11/759,953
Granted
Oct 28, 2008
Kind
B2
Abstract

A fusion protein contains a cysteinized variant of an RNase disclosed in U.S. Pat. No. 6,239,257 B1.

Claims (1)

1. A fusion protein having the amino acid sequence of SEQ ID NO:70.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2020
From: TAMIR BIOTECHNOLOGY, INC.
To: ORGENESIS INC.
Reel/Frame 052892/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2020
From: SAXENA, SHAILENDRA K.
To: ALFACELL CORPORATION
Reel/Frame 052241/0958 →
CHANGE OF NAME Recorded Mar 27, 2020
From: ALFACELL CORPORATION
To: TAMIR BIOTECHNOLOGY, INC.
Reel/Frame 052251/0288 →
Continuity (2)
Division 1062174100 · Jul 17, 2003
Related Publication 20070243605A1 · Oct 18, 2007